This World Breast Cancer Research Day, the Alliance for Clinical Trials in Oncology is highlighting the importance of clinical research in advancing better treatments and improving early detection to ultimately help prevent and cure breast cancer. Although both men and women can develop breast cancer, the disease disproportionately affects women. On average, women in the United States have about a 1 in 8 chance of developing breast cancer during their lifetime, according to the National Cancer Institute. In 2026, an estimated 321,910 women will be diagnosed with breast cancer and about 42,140 will die from the disease. An estimated 2,670 men will also be diagnosed with breast cancer this year.   

The study introduces an integrated engineering framework that combines transcriptomic analysis with a transcriptome-constrained genome-scale metabolic model (GEM) to identify metabolic engineering targets for enhanced bioplastic production. Rather than relying on conventional trial-and-error strain engineering, the approach predicts genetic modifications that redirect metabolic flux toward product biosynthesis, providing a new strategy for agricultural waste valorization and sustainable biomanufacturing.

A team led by researchers from the University of Osaka has used acoustic tweezers to analyze the mechanical properties of biopolymer droplets without needing to physically touch the material. Using this method, the team investigated the stiffness of condensates of a model biopolymer. This technique will further the knowledge of biopolymer droplets and their roles in cellular biology, and may lead to the discovery of novel methods of treating diseases caused by the dysfunction of these droplets.